
Colwin 4.5MIU Injection
Marketer
Cellrox Life Sciences
Salt Composition
Colistimethate Sodium (4.5Million IU)
Overview Colwin 4.5MIU Injection
For severe systemic bacterial infections, the antibiotic Colwin 4.5MIU Injection is administered to hospitalized patients in critical condition. This medication requires professional oversight; self-administration is strictly prohibited. Dosage and treatment length are determined by your physician, tailored to the infection's severity and type. Consistent administration, as directed, is crucial for optimal therapeutic outcomes. Potential side effects, such as nausea, impaired speech, lightheadedness, vertigo, pyrexia, skin rashes, and tingling sensations, are typically transient and resolve with continued treatment. Persistent or bothersome effects warrant immediate medical attention. Prior to commencing treatment, disclose any antibiotic allergies, renal or hepatic impairments to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Regular blood tests may be conducted to monitor kidney function and drug levels.
Uses of Colwin 4.5MIU Injection
Life-threatening bacterial infections
Major Benefits of Colwin 4.5MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Colwin 4.5MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Colwin 4.5MIU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Colwin 4.5MIU Injection works:
Colwin 4.5MIU Injection is a bactericidal antibiotic that disrupts bacterial cell membranes, leading to bacterial death.
SAFETY ADVICE
AlcoholSAFE
There are no adverse reactions reported from concurrent use of Colwin 4.5MIU Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Colwin 4.5MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Colwin 4.5MIU Injection while breastfeeding appears to pose minimal risk. Available data from human studies indicate insignificant danger to the infant.
DrivingUNSAFE
Colwin 4.5MIU Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneyCAUTION
Exercise caution when administering Colwin 4.5MIU Injection to individuals with impaired renal function. Dosage modification for Colwin 4.5MIU Injection may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Colwin 4.5MIU Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Colwin 4.5MIU Injection :
NA
Facts to Know About Colwin 4.5MIU Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
